The Scientific Collaboration in the field of Biomedicine and Health Sciences between the Prince Felipe Research Center Foundation (FCIPF) and the General University Hospital of Valencia Research Foundation (FIHGUV) within the framework of the Translational Research Unit in Tumor Oncology and Immunology (TRIAL Mixed Unit) has been in force since July 19, 2019. Currently, we are working on several research lines in our CIPF laboratory and facilities:
The search for new molecular biomarkers in cancer-focused on early diagnosis and the search for prognostic-predictive factors of treatment response through different omic approaches (genomics, transcriptomics, metabolomics).
Immuneregulation, cancer, and tumor microenvironment. Multidimensional analysis for the characterization of the immunological status in different types of tumors and its application for the discrimination of different immunological scenarios
Presentation
Get to know us better
Research Staff
The people who make it all possible
Publications
Our scientific contributions
dPCR application in liquid biopsies: divide and conquer
A. MORENO-MANUEL, S. CALABUIG-FARINAS, A. OBRADOR-HEVIA, A. BLASCO, A. FERNANDEZ-DIAZ, R. SIRERA, C. CAMPS and E. JANTUS-LEWINTRE
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2021 Jan, DOI: 10.1080/14737159.2021.1860759, Vol. 21, pag. 3-15
CD5 and CD6 as immunoregulatory biomarkers in non-small cell lung cancer
A. MORENO-MANUEL, E. JANTUS-LEWINTRE, I. SIMOES, F. ARANDA, S. CALABUIG-FARINAS, E. CARRERAS, S. ZUNIGA, Y. SAENGER, R. ROSELL, C. CAMPS, F. LOZANO and R. SIRERA
Translational Lung Cancer Research, 2020 Aug, DOI: 10.21037/tlcr-19-445, Vol. 9, pag. 1074
Development of a Multicriteria Decision Analysis Framework for Evaluating and Positioning Oncologic Treatments in Clinical Practice.
Camps C, Badia X, García-Campelo R, García-Foncillas J, López R, Massuti B, Provencio M, Salazar R, Virizuela J and Guillem V
Jco Oncology Practice, 2020 Mar, DOI: 10.1200/JOP.19.00487, Vol. 16, pag. 133
Osimertinib and dihydroartemisinin: a novel drug combination targeting head and neck squamous cell carcinoma.
Chaib I, Cai X, Llige D, Santarpia M, Jantus-Lewintre E, Filipska M, Pedraz C, Cui J, Yang J, Miao J, Sun R, Bracht JWP, Ito M, Codony-Servat J, Karachaliou N, Aguilar A, Rosell R and Cao P
Annals of Translational Medicine, 2019 Nov, DOI: 10.21037/atm.2019.10.80, Vol. 7, pag. 651-651
Lung tumorspheres reveal cancer stem cell-like properties and a score with prognostic impact in resected non-small-cell lung cancer
Herreros-Pomares A, de-Maya-Girones JD, Calabuig-Fariñas S, Lucas R, Martínez A, Pardo-Sánchez JM, Alonso S, Blasco A, Guijarro R, Martorell M, Escorihuela E, Chiara MD, Duréndez E, Gandía C, Forteza J, Sirera R, Jantus-Lewintre E, Farràs R and Camps C
Cell Death & Disease, 2019 Sep, DOI: 10.1038/s41419-019-1898-1, Vol. 10, pag. 660-660
FUNDING
Thank you for supporting us
